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Originally, the peroxisomal targeting signal 1 (PTS1) was defined as a tripeptide at the C-terminus of proteins prone to be imported into the
peroxisomal matrix. The corresponding receptor PEX5 initiates the translocation of proteins by identifying potential substrates via their C-termini
and trapping PTS1s through remodeling of its TPR domain. Thorough studies on the interaction between PEX5 and PTS1 as well as sequence-
analytic tools revealed the influence of amino acid residues further upstream of the ultimate tripeptide. Altogether, PTS1s should be defined as
dodecamer sequences at the C-terminal ends of proteins. These sequences accommodate physical contacts with both the surface and the binding
cavity of PEX5 and ensure accessibility of the extreme C-terminus. Knowledge-based approaches in applied Bioinformatics provide reliable tools
to accurately predict the peroxisomal location of proteins not yet determined experimentally.
© 2006 Elsevier B.V. All rights reserved.Keywords: PTS1; PEX5; Targeting; Peroxisome; PredictorTo fulfill their cellular function proteins need to be
transported to their final destination. This process always
involves targeting signals, receptors and docking proteins. For
example, proteins targeted to the ER, the mitochondria or the
chloroplasts usually comprise an N-terminal signal recognized
by distinct receptors which in turn initiate a sequence of events
leading to their translocation. Mitochondria and chloroplasts
use the nuclear encoded gene products to complement their
autonomously synthesized set of proteins. Peroxisomes neither
contain DNA nor do they hold their own protein synthesis
machinery and, therefore, import their complete protein content
from the cytosol. Interestingly, a high number of peroxisomal
proteins are oligomeric and some peroxisomal proteins do
contain prosthetic groups such as heme or FAD.
Considering the biological and medical significance of sub-
cellular compartmentalization, predictions of the right protein
location exclusively based on the amino acid sequence
constitute a major advancement in modern biology. However,
such prediction is only possible with a clear conception of the
signal and its interaction partners. In this review we summarize⁎ Corresponding author. Tel.: +43 1 4277 52817.
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0167-4889/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.08.022the current knowledge on the C-terminal peroxisome targeting
signal 1 and we wish to put forward a new definition.
1. PTS1 is a C-terminal amino acid sequence
Amajor breakthrough in the elucidation of the mechanism of
protein import into peroxisomes was reached about twenty
years ago when Keller et al. [1] while working with
recombinant luciferase of the firefly Photinus pyralis as a
reporter protein expressed in monkey kidney cells found that the
protein colocalized with catalase in peroxisomes. Following this
surprising finding luciferase was localized to the peroxisomes
of the lantern organ of the firefly. Moreover, using genetic
engineering and immunofluorescence microscopy Gould et al.
[2] identified a region at the C-terminus of luciferase that was
necessary and sufficient to direct proteins to peroxisomes
defining the first peroxisome targeting signal (PTS1). Today we
know that the majority of peroxisomal matrix proteins contain
such a PTS1. Very few proteins contain an N-terminal PTS2.
Like most peroxisomal matrix proteins, luciferase is not
processed after translocation into peroxisomes [3]. Import into
peroxisomes therefore differs from the import mechanisms into
the endoplasmic reticulum, mitochondria or chloroplasts in
which the targeting signal is located at the amino-terminus of
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immediately after translocation. As a consequence of its
carboxy-terminal topology, peroxisomal matrix proteins har-
boring a PTS1 have to be fully synthesized in the cytosol prior
to their import. Amino acid insertions or deletions far away
from the C-terminus disrupted the translocation [2] and the
authors of this work already reasoned that alteration of the
three-dimensional structure could be the cause of the targeting
impairment. Remarkably, accessibility of the signal was already
a matter in the first report on PTS1.
Site directed mutagenesis in luciferase led to the identi-
fication of the PTS1 as the tripeptide Serine–Lysine–Leucine
(–SKL) at the extreme C-terminal end of the protein [4].
Additional mutagenesis experiments revealed that variants of
the PTS1 may exist that conserve the property of a translocation
signal and target either luciferase or the chimera chloramphen-
icol-acetyl-transferase (CAT)-luciferase into peroxisomes of
CV-1 cells [4,5]. Finally, amino acid residue permutations soon
yielded an extended definition of the PTS1-consensus
sequence: amino acids at the first position contain a small
uncharged side chain (S/A/C), at the penultimate position
a positively charged residue (K/R/H) and at the extreme
C-terminal position leucine [4,6]. Many peroxisomal proteins
indeed contain a genuine PTS1 adhering to the original
consensus, except the prototype of peroxisomal proteins,
catalase. Besides an unusual C-terminus yeast catalase A
contains an internal targeting signal [7] and the import of human
catalase was demonstrated to depend on its C-terminal
tetrapeptide [8]. Nevertheless, it became soon obvious that the
presence of the consensus tripeptide does not suffice for
peroxisomal targeting. PTS1 is not a guarantee for import of
proteins across the peroxisomal membrane [9,10]. The
canonical PTS1 –SKL attached to the carboxy terminus of the
mouse dihydrofolate reductase [7,11] or the signal –AKI fused
to the C-terminus of CAT [9] did not lead to the targeting of the
reporter proteins to peroxisomes in the yeast Saccharomyces
cerevisiae whereas the C-terminal SKL-tagging of CAT was
sufficient for its import into the peroxisomal matrix. When its
C-terminus was extended by 6 or 7 amino acids ending in the
sequence SKL DHFR was targeted to peroxisomes clearly
indicating that the extreme C-terminus should be accessible for
correct transport. The opposite has also been found and proteins
have been reported that do not need their PTS1 to be imported
via the PTS1-receptor pathway. Deletion of the C-terminal
sequences of either isocitrate lyase from castor bean or catalase
A or carnitine acetyltransferase from S. cerevisiae did not
prejudice their import into peroxisomes in this yeast [7,12,13].
It is important to point out that in most studies either
heterologous expressed proteins (e.g. firefly luciferase in Try-
panosoma brucei or CV-1 cells) or non-peroxisomal reporter
proteins (e.g. CAT; DHFR) were used which may have
influenced the findings leading to the definition of the PTS1.
At the time of its discovery the C-terminal location of the
PTS1 was surprising but provided a good explanation for the
post-translational mode of transport into peroxisomes [14].
Subsequently, it was demonstrated that proteins can enter the
peroxisomal matrix in a folded or oligomerized state [15–17].The PTS1 does not even need to be part of the primary sequence
of a protein instead it could be conjugated with the protein to be
imported [15,18]. McNew and Goodman [16] demonstrated that
oligomerized proteins are translocated across the peroxisomal
membrane using CAT as a reporter protein. The mature form of
CAT is a homotrimer; its oligomerization takes place in the
cytosol within a few minutes. The analysis of co-expressed CAT
extended by a PTS1 at its carboxy-terminal end together with
both a hemagglutinin-tagged version of CAT (HA-CAT) lacking
PTS1 and a truncated version of CATwithout PTS1 showed that
the two PTS1-less versions of CAT were imported into
peroxisomes. Stoichiometric analysis of the imported trimers
confirmed, that at least one subunit of each trimer harbored a
PTS1. Additional experiments demonstrated that peroxisomal
proteins cross-linked or stabilized with disulfide bonds, mature
folded proteins and PTS1-harboring IgG as well as colloidal
gold particles (9 nm) conjugated to PTS1-containing human
serum albumin (HSA) were all efficiently imported into
peroxisomes [17].
These results could suggest that peroxisomal proteins have to
be completely folded prior to their import into the organellar
matrix, a step which could serve as quality control for entry into
peroxisomes. Only mature and enzymatically active proteins
would enter the organelle, and cofactor-binding or oligomeri-
zation processes occur outside prior to the translocation step.
However, in vivo experiments with reduced albumin bearing a
PTS1 indicate that proteins can be substrates for peroxisomal
import despite their inability to assume their native conforma-
tion [19], suggesting that PTS1 is the major requirement for
entry into the peroxisomes and that no other quality control
exists at the substrate protein level. Obviously, it makes no
difference for peroxisomal translocation whether proteins are
folded and assembled or not. However, peroxisomes save the
need for import of co-factors or assembly components when
importing fully functional proteins. These observations
support the benefit of C-terminal sequences as targeting
signals, although such signals are disadvantageously placed
very low in the hierarchy of targeting signals [20]. Decisions
for the localization of proteins are made according to the flow
of their synthesis from the N-terminus to the C-terminus. The
N-terminal sequence leaving the ribosome is tested for its
interaction with the signal recognition particle (SRP) and either
bound followed by ER-translocation or not, the presence of
mitochondrial or chloroplast targeting signals at the N-terminus
is scanned and transmembrane regions are determined by their
hydrophobic properties. Only after the tertiary structure is
adopted the protein is transported either into the nucleus or into
peroxisomes or becomes a cytosolic resident.
2. PTS1 is universal but species-specific
Antibodies raised against the short amino acid sequence SKL
specifically recognized multiple peroxisomal proteins in various
species [21]. The enzyme luciferase was used as reporter protein
and was localized into peroxisomes of yeasts, plants and
mammals when expressed in those cells [22] supporting the
universality of peroxisomal import mechanisms and the
1567C. Brocard, A. Hartig / Biochimica et Biophysica Acta 1763 (2006) 1565–1573hypothesis that peroxisome targeting may have been conserved
throughout evolution of eukaryotes. Studies on the PTS1-
dependent peroxisomal matrix protein transport in yeasts
[11,23], plants [24,25], mammals [18] and trypanosomes
[26,27] corroborated this assumption.
A detailed analysis of the PTS1 in yeast by Aitchison et al.
[9] demonstrated that the PTS1 of the multifunctional enzyme
(hydratase–dehydrogenase epimerase) of Candida tropicalis
was contained in its C-terminal sequence –AKI which was also
necessary to target the ectopically expressed protein to
peroxisomes in both Candida albicans and S. cerevisiae.
However, substitutions within this tripeptide to GKI or AQI
supported targeting to peroxisomes in C. albicans but no longer
in S. cerevisiae. Additional mutational studies with luciferase in
T. brucei indicated that the PTS1 consensus may be more
relaxed for lower eukaryotic organisms than for mammalian
cells [5,28,29]. These and further studies [30,31] supported a
new definition for PTS1 aside from the archetype sequence
–SKL with a small neutral amino acid residue at the first
position of the tripeptide (A/C/G/H/W/P or T), an amino acid
residue capable of hydrogen bonding at the penultimate position
(H/M/N/Q/R or S) and an hydrophobic amino acid residue (I/M
or Y) at the extreme carboxy terminus [26]. These studies posed
for the first time the question of a species-specificity in the
import mechanism of peroxisomal proteins similar to the
carboxy terminal tetrapeptides KDEL, HDEL or DDEL used for
retrieval of proteins to the ER in different species [32,33]. The
variations observed may represent an evolutionary divergence
in the peroxisomal targeting signals and their recognition by the
cognate receptors.
Elgersma et al. [34] studied the PTS1 degeneracy in a
homologous context using the malate dehydrogenase (MDH3)
of S. cerevisiae. Many of the PTS1-variants found did not fit the
PTS1-consensus previously defined to target heterologous
proteins. Therefore, the authors assumed that similar to the
context dependence of the nuclear localization signal the PTS1
may have to be specifically presented in order to be bound by
the cytosolic receptor that in turn will target the protein to the
peroxisomal membrane. A systematic study was performed in
our laboratory applying the two-hybrid system [35] with a
peptide-library [36] to screen for peptides interacting specifi-
cally with the PTS1-binding domain of either the human PTS1-
receptor or the one from the yeast S. cerevisiae. We noted a
much broader degeneracy for the human and the yeast PTS1
than the original consensus [37]. Among the novel PTS1
peptides identified with the human receptor only very few
bound the yeast receptor demonstrating a species-specific re-
cognition process. Moreover, in our screen peptides ending with
the same tripeptide bound the PTS1-receptor with various
efficiencies [37]. The only difference between these peptides
resided in the upstream region indicating that PTS1 is more than
just a C-terminal tripeptide.
An explanation for these differences may be that like in a
default pathway PTS1-containing proteins would be targeted to
peroxisomes unless the region upstream to the PTS1 inhibits the
interaction with the receptor. Consequently, no transport across
the peroxisomal membrane would occur regardless of thecontext of the protein. Thus the species differences observed
may reside in a modulating specificity that during evolution
became more subtle to guarantee that proteins are properly
compartmentalized to peroxisomes.
Genetic evidence suggested the existence of a third import
pathway. Zhang et al. [38] isolated an onu-mutant (peb5) in the
yeast S. cerevisiae impaired in import of catalase (frequently
used as PTS1-protein marker). Moreover, in these mutants the
PTS2-containing protein thiolase and acyl CoA oxidase (AOX)
were both correctly imported into the peroxisomal matrix. The
authors concluded that AOX uses an import pathway different
from PTS1 or PTS2. Studies in our lab by Kragler et al. [7]
revealed that in the yeast S. cerevisiae catalase A is targeted to
peroxisomes whether or not it contains a PTS1 at its extreme
C-terminus. In addition, we demonstrated that the integrity of
the region between amino acids 125 and 140 is necessary for its
location [7], and the 126 N-terminal amino acid residues serve
as targeting signal (in a PEX7-independent manner). Surpri-
singly, Elgersma et al. [12] described that carnitine acetyl-
transferase could be imported into peroxisomes of S. cerevisiae
without any of the two defined targeting signals. Similar to
catalase the latter enzyme did not need its PTS1 to be imported.
Despite these findings the existence of a third import pathway
remains doubtful since deletion of the PEX5 gene encoding the
PTS1-receptor totally abolished import of both catalase A and
carnitine acetyltransferase [12,39]. Moreover, preliminary
results in our laboratory showed that the yeast AOX interacted
with ScPEX5 in the two-hybrid system (Lametschwandtner, G.,
unpublished data). These results can be interpreted in different
ways: (1) an additional receptor exists whose activity depends
on the presence of PEX5. No such receptor was reported; (2)
another possibility is that certain proteins do contain sequences
necessary for interaction with PTS1-containing proteins with
which they oligomerize and are co-imported into the peroxi-
somal matrix via the PTS1-import pathway [15,16]. A detailed
analysis of the structure of such required regions might help to
answer this question. (3) Alternatively, these proteins may
interact with PEX5 avoiding the PTS1-binding cavity.
3. PEX5 recognizes PTS1 via its TPR domain
With the signal for translocation into the peroxisomal matrix
at hand the next challenge was to identify the corresponding
receptor(s). Which factor(s) recognize the C-terminus of
peroxisomal matrix proteins? In the yeast S. cerevisiae mutants
have been described that are impaired in either PTS-dependent
transport [40]. The gene able to complement the defect in the
PTS1-protein transport was cloned from various species and
later commonly named PEX5 [39,41–43]. A common feature in
the mutant analysis was that cells were defective in growth but
not in division of peroxisomes, as demonstrated in the pex5-
mutants of Pichia pastoris [41] or Hansenula polymorpha [42].
Since PTS1-containing proteins were properly expressed and
induced, these studies led to the conclusions that the PTS1-
import pathway is impaired in pex5-mutant cells and that PEX5
represents the PTS1-receptor. In vitro-translated PpPEX5
protein could be bound to immobilized peptides terminating
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hints for the function of PEX5 as PTS1-receptor.
An alternative strategy exploited the two-hybrid system
using PTS1 as bait. This approach resulted in the identification
of ScPEX5 as interaction partner [44]. With a meticulous
characterization of the interaction between bait and prey-
fragments we demonstrated that the PTS1-peptides physically
interact with the C-terminal half of PEX5 containing the
tetratricopeptide repeat (TPR)-domain, which was splendidly
corroborated by the crystal structure 6 years later [45].
According to this 3D-structure, the PTS1 appears to be locked
in a groove with various interactions towards both sets of 3
TPR-motifs linked together by a helical hinge (Fig. 1).
TPR-containing proteins are involved in numerous protein–
protein interactions. Although the sequence conservation
among the TPRs is very low, these motifs fold into a very
similar compact conformation of two short antiparallel alpha-
helices termed A and B separated by a turn [46]. At least three of
these repeats are stacked upon each other forming a particularly
shaped surface resembling a bent half-pipe, with the A-helices
of the individual repeats building the inner concave surface. The
conserved amino acids responsible for the structural shape are
buried, and the variable ones in the helices or in the turn
between the two short α-helices in each of the repeats are
exposed at the surface. The structure formed by staggering the
repeats provides a distinct surface for protein–protein interac-
tions, the specificity of which is determined by amino acid
residues not involved in structure formation.
Besides the recognition of PTS1 by PEX5 another well-
characterized protein–protein interaction involving a TPR
domain is the one between the adaptor protein Hop and the
C-termini of the two molecular chaperones Hsp70 and Hsp90
consisting of the amino acid sequence –EEVD [47]. Hop
contains two TPR domains, both recognize identical amino acid
sequences and each one is able to form a “two-carboxylate
clamp” tightly interacting with the ultimate aspartate of the
Hsps. Among the 11 proteins forming the mammalian ana-
phase-promoting complex (APC), 4 contain TPR domains:
APC3, 6, 7 and 8. Two of these, namely APC3 and APC7 [48],Fig. 1. PEX5 recognizes C-terminal ends and successful interaction closes the
PEX5 clamp.were shown to interact with C-terminal dipeptide motifs (–IR).
Altogether, these examples suggest that TPR domains recognize
short C-terminal stretches of amino acids to identify proteins for
interaction.
The TPR-domain of the ScPEX5 is necessary to bind the
C-terminal sequence –SKL in a two-hybrid system [44].
Moreover, the amino acid residues beyond the TPR-domain
do not provide binding specificity, illustrated by the finding that
the two-hybrid interaction between ScPEX5 harboring a
modified C-terminus and an SKL-containing protein was not
impaired (Brocard, C., unpublished data). The TPR-domain
provides the specificity to discern PTS1 and should therefore be
responsible for species-specific differences. The N-terminal half
of ScPEX5 fused with the C-terminal half of a plant receptor
NtPex5 restored peroxisomal import in S. cerevisiae pex5-
mutant cells [49]. Similarly, a fusion between the N-terminal
part of the PpPEX5 and the C-terminal half of the HsPEX5
containing the TPR domain was able to rescue import of some
PTS1-proteins in the pex5-mutant of the yeast P. pastoris [50].
These results do not only prove the functional homology of
these factors but they also suggest that the peroxisomal import
machinery is conserved from yeast to plant and human.
However, two groups observed that the fusion PpPEX5p–
HsPEX5 failed to complement the methanol growth defect of
the P. pastoris pex5-mutant cells [50,51]. Therefore, Dodt et al.
[51] proposed that the differences in peroxisomal import
observed between organisms may reside in the aptitude of the
TPR-domain to recognize the PTS1. The sequence selectivity in
human and monkey cells excludes a phenylalanine at the
extreme C-terminus of the PTS1, but the P. pastoris alcohol
oxidase terminates with the sequence –ARF. It was shown that
in the P. pastorismutant strain complemented by the expression
of a chimera PpPEX5p–HsPEX5 protein alcohol oxidase was
indeed not imported clearly illustrating that the TPR domain of
PEX5 determines the PTS1 sequence specificity of the
organism.
Unlike the mitochondrial receptors Tom20 and Tom70 none
of the PEX5 proteins identified so far contain a hydrophobic
domain that could lead to their anchoring in the peroxisomal
membrane. Although there is no doubt about the function of
PEX5 as PTS1-receptor the exact mechanism of import of
PTS1-proteins remains elusive. The receptor has been localized
in different parts of the cells depending on the organism studied.
Common assumption would assign this interaction to the
peroxisomal membrane, and indeed many experimental results
pointed into this direction. Isolated peroxisomes could be bound
to immobilized peptides [52], labeled PTS1 was bound to
glyoxysomal membranes [53], and human PEX5 protein was
found to be associated with peroxisomes [54]. In summary, all
evidence suggested a membrane-bound protein to be responsi-
ble for binding PTS1. A contrasting view was provided by Dodt
et al. [51] showing that more than 90% of human PEX5 protein
is cytosolic, culminating in the commonly accepted view that
PEX5 shuttles between the cytosol and the peroxisomes [55].
The daring hypothesis that the whole PEX5 protein transverses
the peroxisomal membrane is still a matter of debate [56]. The
discrepancies observed in the PEX5 subcellular localization
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observation that PEX5 is mainly associated with the membrane
[41,52] was an experimental artefact. Gould et al. [57] have
shown that in the cytosol PEX5 exhibited a very pronounced
protease sensitivity which was inhibited only by the addition of
NaF in the buffers used for extractions. Nevertheless, HsPEX5
and ScPEX5 were found mainly in the cytosolic fraction and
only a small fraction associated with peroxisomes [34,58].
Among all organisms so far only in H. polymorpha and Yar-
rowia lipolytica PEX5 was localized to the peroxisomal matrix
[42,43]. It is unlikely that these two yeasts use a different
mechanism of import, since it was shown that the import of
peroxisomal matrix proteins is highly conserved throughout all
organisms studied. Alternatively, as a variation to the general
import mechanism PEX5 might be completely released into the
peroxisomal matrix or its export might be extremely slow under
certain environmental conditions. In both cases PEX5 would be
detected in the peroxisomal matrix of these organisms whereas
in others this might be a short-lived transition state only.
Regarding all these results the dual location of PEX5 in the
cytosol and at the peroxisomes resembles more a bimodal
distribution. Therefore, import of PTS1-proteins into peroxi-
somes may function in a manner analogous to the post-
translational import into the ER lumen with binding of the
transport substrate to PEX5 in the cytosol and targeting of the
complex to the translocation machinery. Upon release of the
PTS1-protein at the organellar membrane with the help of other
peroxin(s) the receptor recycles back to the cytosol for another
round of interaction or becomes degraded by the proteasome. In
this model it is conceivable, that PEX5 is able to associate with
the peroxisomal membrane only if it is loaded with its PTS1-
containing cargo as suggested [59].
4. Predicting a PTS1
Sequence-analytic tools were developed to screen for new
potential peroxisomal matrix proteins based on the C-terminal
consensus sequence. Efficiency and success essentially depend
on both the data input and the prediction method. Is the PTS1
really a simple tripeptide or should more care be taken when
predicting the location of PTS1-containing proteins? Some
methods are only based on the analysis of the C-terminal
tripeptide of proteins which may give rise to misleading results.
PSORT applies an algorithm including the C-terminal
sequences [A/C/S]–[H/K/R]–L with modest performance for
peroxisomal proteins due to its restricted sequence selection,
whereas PROSITE uses a pattern that is too promiscuous to
restrict the results to peroxisomal proteins [A/C/G/N/S/T]–[H/
K/R]–[A/F/I/L/M/V/Y]. Similarly, to detect peroxisomal matrix
proteins in silico, a conceptually translated protein database of
the entire yeast genome was analyzed searching for the pep-
tides [S/A/C]–[K/H/R]–L, [S/A]–[Q/N]–L, and S–K–F at the
C-terminus of proteins of 100 amino acids or longer [60]. Some
of the novel proteins were tested for peroxisomal translocation
via GFP-fusion at the N-terminus followed by the determination
of the intracellular location of the fusion proteins, but not all of
them were imported into the peroxisomal matrix. Clearly, fusionproteins may represent a particular problem in localization
experiments, but in addition, the decision to limit the search to
the tripeptide neglected some other features of the signal such as
the physical properties of the amino acids involved or the signal
accessibility. A more elaborate approach was performed by
Emanuelsson et al. [61] feeding the C-terminal amino acid
sequences of all truly peroxisomal proteins from databanks into
a learning set in comparison with non-peroxisomal proteins
harboring a PTS1-like C-terminus (relaxed consensus motif [A/
C/H/K/N/P/S/T]–[H/K/N/Q/R/S]–[A/F/I/L/M/V]). The final
PeroxiP prediction scheme excludes secreted and trans-mem-
brane proteins prior to the motif identification and depending on
the settings used is either restrictive missing known peroxisomal
proteins or rather permissive with too many false positive
results. A similar strategy i.e. searching whole genomes for the
appearance of well-known PTS1s at the C-termini of Arabi-
dopsis thaliana proteins was applied to create the subset of
peroxisomal matrix proteins in the database AraPerox [62].
Kurochkin et al. [63] analyzed the whole rodent and primate
GenBank of translated mRNA sequences for the occurrence of
the C-terminal tripeptide [S/A]–K–L.
All these approaches are based on experimentally verified
locations of peroxisomal proteins, which represent a limited set
of proteins. Localization processes include not only the
interaction with the corresponding receptor, which mainly
depends on the signal and its accessibility, but also on the
successful process of translocation itself. This in turn includes
many other interactions and crossing barriers not directly
associated with the function of the targeting signal. In fact, the
potential of a given amino acid sequence to act as a targeting
signal depends solely on its capability to initialize the
translocation process through its interaction with the receptor.
Therefore, approaches shielding the interaction between signal
and receptor from all subsequent events should provide more
reliable data on the putative targeting function of all possible C-
terminal endings. Such a possibility is offered by the two-hybrid
system employing PEX5 or its essential TPR domain as bait and
a library expressing short peptides (16-mers) fused to the C-
terminus of the GAL4 activation domain [36]. C-terminal amino
acid sequences identified through this approach are able to
interact with the TPR domain of the PEX5 protein fulfilling all
requirements to act as PTS1. A comparison between peptides
interacting with TPR domains from different organisms
revealed species-specific recognition features as well as the
influence of amino acid residues immediately upstream of the
C-terminal peptide [37,49]. However, all peptides ending with
the original consensus tripeptide are recognized by all PEX5
proteins tested, with the affinities varying according to the
upstream regions.
The affinity of the receptor PEX5 for PTS1 signals has been
measured in vitro with bacterially expressed HsPEX5L and a
fluorophore-containing peptide lissamine-YQSKL. The disso-
ciation constant was measured to be 35 nM as compared with an
affinity 250 nM for PpPEX5 with the same peptide [64]. This
shows again that signal recognition appears to be species-
specific and that different requirements might be set for PTS1
binding in different organisms. In this study PEX5 behaved as a
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in vivo one could expect the interaction to be facilitated by the
presence of factors that alter the folding of the protein or
enhance the presentation of its PTS1. A candidate for such
action has been proposed to be Hsp70. However, Harper et al.
(2003) demonstrated that the presence of Hsp70 had no effect
on PEX5:PTS1 interaction. Similarly, the presence or absence
of ATP did not affect interaction suggesting that if ATP is
required in the import process this step happens downstream of
the PEX5:PTS1 binding event [64].
In further studies PEX5 binding affinities were determined
in vitro with peptides of different length and with some
sequence variations [54,65,66]. Longer peptides bind to the
TPR domain of PEX5 tighter than shorter ones (3–6 times), and
amino acids upstream of the ultimate tripeptide influence the
affinity between the C-terminal end and its receptor. These
studies corroborate previous observations from 2-hybrid studies
in yeast employing hexadecapeptide extension at the GAL4
activation domain that demonstrated that the amino acid context
upstream of the C-terminal tripeptide does play a important role
in the binding affinity to the receptor and some residues are
favored such as leucine or valine at position –5 [37].
One should keep in mind that in these in vitro- or two-hybrid
studies of interaction between PEX5 and peptides all potential
interactions with PEX5 outside of the PTS1 binding pocket are
abolished making the whole system artificially stable due to a
lower structural demand. Considering the bipartite structure of
the C-terminal part of PEX5 with two triplets of TPR domains
building the contacts with the PTS1 signal [45], it is
conceivable that other contacts exist with sequences upstream
of the tripeptide that would account for the stability of the
interaction and consequently for the efficiency of transport. For
instance, the whole TPR domain could function as a trap for
PTS1-containing proteins provided that it can close properly
upon binding. Clearly, a tightly folded globular structure of a
potential substrate protein would not accommodate the closure
of the receptor. The extreme C-terminal end of the proteins
carrying a PTS1 must be accessible and presented to the
receptor. In the trapping scenario, the amino acid residues
upstream of the C-terminal tripeptide would play an essential
role in two ways: (1) structurally, because steric hindrance may
be an important factor near the last three amino acid residues
and (2) qualitatively, if other binding sites exist in PTS1-
proteins that affect the affinity for PEX5. All studies on the
PTS1 degeneracy and the extension of the original consensus
suggest that the definition of the C-terminal targeting signal
should be amended and residues upstream of the ultimate
tripeptide should be included into the PTS1 [65,67].
C-terminal sequences identified solely by means of interac-
tion with the TPR domain of PEX5 proteins yielded a list of
peptides possibly recognized by the corresponding receptors,
i.e. a list of potential signals regardless of their natural
occurrence and unprejudiced by subsequent events. This set
of C-terminal sequences together with the C-termini of
experimentally verified peroxisomal matrix proteins repre-
sented a learning set to refine the PTS1-motif and to develop
a novel and highly accurate predictor [68]. Based on the aminoacid composition at the very end of peroxisomal matrix proteins
compared to non-peroxisomal proteins and considering the
structural constraints intrinsic to the contact with the TPR
domain of PEX5, PTS1 was divided into three regions [68]. The
most C-terminal tripeptide is responsible for interaction with the
PEX5-cavity [45], a tetrapeptide immediately upstream is
thought to interact with the surface of the PEX5 proteins, and
a flexible hinge accounts for accessibility and flexibility, which
corresponds altogether to a 12-amino acid sequence.
This refined PTS1 motif description served as a source to
develop a prediction tool capable of detecting PTS1 C-termini
in yet uncharacterized protein sequences. The score function S
consists of two components, the Sprofile evaluates the concor-
dance with amino acid type preferences and Sppt penalizes
deviations from the physical property pattern derived from the
learning set. Query sequences that generate scores larger or
equal to 0 are considered “predicted”, sequences with scores
below –10 are classified as “not predicted”, and sequences with
scores between 0 and –10 are considered being situated in a
“twilight zone” http://mendel.imp.ac.at/mendeljsp/sat/pts1/
PTS1predictor.jsp).
The novel predictor was applied to protein sequences
originally examined in mutational analyses to define the PTS1
and its variants. Although predictor performance exceeded by
far the pattern-based methods of PSORT or PROSITE, it failed
to recognize some unusual but already verified targeting signals
on MDH3 terminating with E–K–L or S–Y–L [34]. An
explanation could be that their targeting function is due to the
presence of additional interactions which would improve the
competence of this particular protein to be addressed to the
peroxisomal matrix. Nonetheless, the addition of –SKL alone
to the C-terminus of DHFR was correctly classified as “not-
peroxisomal” since the score Sppt was strongly negative.
Accordingly, longer extensions at the C-terminus of DHFR
consisting of amino acid sequences –KNIESKL or –GGKSKL
resulted in positive prediction and experimentally in successful
translocation. As an example we applied the predictor to a
number of 2,4 dienoyl-CoA reductases identified through a
BLAST search as homologues of ScSPS19. In Table 1 the
PTS1-predictor is compared with the established PSORTII [69].
When the predictor was applied to all SWISSPROT entries
or to bacterial proteins it classified a number of proteins as
targeted to peroxisomes that never encounter this organelle. In
most cases the C-termini did not diverge from the derived
consensus and could not be rationalized as false-positive
predictions. Therefore, selected C-termini were tested for
interaction with PEX5 in two-hybrid assays and in vivo the
localization of the corresponding proteins fused to GFP at
their N-termini was determined [20]. All tested C-termini
interacted with the TPR domain of PEX5 proteins, and acted
as functional PTS1 provided that the competing targeting
signal was disguised or eliminated. The occurrence of a
functional PTS1 signal does not convey evolutionary pressure
since mislocalization is normally prevented by overriding the
function of these C-terminal sequences either via exposure of
N-terminal signals or through structural seclusion. Conse-
quently, these signals remain silent under normal phy-
Table 1
2,4 dienoyl-CoA reductases and their intracellular location in various organisms
Species GI Dodecapeptide PTS1-predictor (Score) PSORT-II Reference
Yarrowia lipolytica CAG81681 –MLIAQGNDTPKL Twilight (−5.180) 70% Cyto
CAG79530 –TVIVQGNKPPKL Targeted (2.226) 48% Cyto
CAG80482 –MLKHMGEDKSKI Twilight (−0.701) 57% Cyto
Candida albicans XP_712761 –VIHQNEDPQGKL Twilight (−7.433) 61% Cyto
XP_713778 –GTEGMSRLITFK Not targeted (−49.126) 61% Cyto
XP_713744 –LNAINAPKGGKL Twilight (−9.456) 52% Cyto
Candida glabrata XP_447149 –PDLLFKDPKAKL Targeted (5.439) 33% Px
Saccharomyces cerevisiae NP_014197 –PEALIKSMTSKL Targeted (2.239) 78% Px [72] Px
Aspergillus nidulans XP_681039 –FQNVKGKKKAKL Targeted (10.023) 44% Cyto
Neurospora crassa XP_328664 –KNLKDGRQKSKL Targeted (13.266) 67% Px
Kluyveromyces lactis XP_453899 –PKELNYAFDSKL Twilight (−7.045) 78% Px
Caenorhabditis elegans CAA90268 –NLIRGRTGKEKA Not targeted (−33.897) 44% Cyto [73] Predicted Mito
CAA91310 –NVIRGRTGKEKP Not targeted (−32.941) 35% Cyto
35% Mito
CAB02118 –RGRTGKEKKSKL Targeted (8.457) 67% Px [73] Predicted Px
Mus musculus NP_036063 –QLLEFESFSAKL Targeted (4.290) 44% Cyto [74] Px
NP_076012 –RIKESFKKKAKL Targeted (6.083) 39% Cyto [75] Px
NP_080448 –IIEGLIRKTKGS Not targeted (−83.937) 44% Nu [76] Mito
Rattus norvegicus NP_741993 –RLLEFESSSAKL Twilight (−0.324) 48% Cyto [77] Px
NP_579833 –KVKESLKKQARL Targeted (−5.84) 48% Nu
NP_476545 –VIEGLIRKTKGS Not targeted (−83.334) 44% Mito [78] Mito
Homo sapiens NP_001350 –TLEELIRKTKGS Not targeted (−81.551) 65% Mito [79] Mito
NP_065715 –GLPDFASFSAKL Targeted (−6.964) 39% Cyto [80] Px
NP_060911 –KMKETFKEKAKL Targeted (−4.383) 44% ER [81] Px
Arabidopsis thaliana BAD94126 –RAKPVGLPTSKL Targeted (−16.448) 78% Px
The locations indicated in the columns are: Cytosolic (Cyto), Endoplasmic reticulum (ER), Mitochondrial (Mito), Nuclear (Nu) or Peroxisomal (Px).
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important in future evolutionary scenarios or in pathological
situations. In line with these observations, it seems that cells
only exploit a fraction of the potential molecular capacities of
their proteins.
5. Concluding remarks
In summary, PTS1s are defined as C-terminal dodecamers
able to interact with the TPR domain of PEX5 proteins. These
sequences comprise the potential to initialize a peroxisomal
translocation event via their interaction with PEX5 proteins.
This interaction alone is certainly not sufficient to bring the
entire translocation process to an end. Accessibility, lack of
competition with other hierarchically more important signals, or
simply the presence of target organelles are just as important,
but without the potential to interact with PEX5 the translocation
process of PTS1-containing proteins to peroxisomes would not
even resume.
A sequential model for the initial steps of import includes a
first contact between the extreme C-terminus, possibly just a
tripeptide, of a potential cargo with some residues of the TPR
domain of a PEX5 protein. This primary interaction would
lead to the closure of the clamp formed by the TPR domain,
the state observed in the crystal structures. Further contacts
between the 12-mer and the TPR domain are consistent with
the final affinity describing the ability of a particular sequence
to act as a PTS1. Partial or complete inaccessibility or residues
detrimental to the interaction would preclude the closure of the
TPR clamp and thus inhibit the flow of the import process.Once the cargo is bound to the TPR domain the translocation
starts, but finally the cargo has to be released and the
interaction of PTS1 with the TPR domain needs to be
reversed. In the future, crystal structures of full-length PEX5
proteins in its loaded and unloaded state will certainly help to
elucidate the releasing step.
Understanding sub-cellular location and transport of protein
has greatly increased the knowledge of genetically inherited
diseases. In fact, mutated signal peptides can target proteins to
the incorrect place in the cell leading to pernicious clinical
symptoms. For instance cystic fibrosis is a lethal illness caused
by defective channel protein transport to the plasma membrane
[70]. Mistargeting of peroxisomal proteins can also have
dramatic effects on health as exemplified by the mislocalization
of alanine:glyoxylate aminotransferase which has been reported
to be the cause of the hereditary disease primary hyperoxaluria
responsible for the formation of kidney stones in youth [71].
In conclusion, the exact knowledge of proteins with their
signals and their mode of transport in the cell is a prerequisite
for the comprehension of innumerable illnesses and the
subsequent discovery of new treatments. Indeed, studies around
protein targeting have direct practical applications in our society
such as the production of curative proteins, or the development
of efficient and affordable diagnosis along with the advance-
ment of therapeutic strategies.
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